|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-12-22
|
|
pubmed:abstractText |
Trimetazidine (TZM) has been shown to have anti-ischemia properties by optimizing ischemic myocardium metabolism. We evaluated the effect of TZM on myocardial metabolism with Positron Emission Computed Tomography (PET-CT) in patients with ischemic cardiomyopathy.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0253-3758
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
36-9
|
|
pubmed:dateRevised |
2011-10-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19099925-Aged,
pubmed-meshheading:19099925-Aged, 80 and over,
pubmed-meshheading:19099925-Female,
pubmed-meshheading:19099925-Humans,
pubmed-meshheading:19099925-Male,
pubmed-meshheading:19099925-Middle Aged,
pubmed-meshheading:19099925-Myocardial Ischemia,
pubmed-meshheading:19099925-Myocardium,
pubmed-meshheading:19099925-Positron-Emission Tomography,
pubmed-meshheading:19099925-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:19099925-Trimetazidine
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
[Effects of trimetazidine on myocardial metabolism evaluated by PET-CT in patients with ischemic cardiomyopathy].
|
|
pubmed:affiliation |
Sichuan Province Medical-sciences Institute & Sichuan Province People's Hospital, Chengdu 610072, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract,
Randomized Controlled Trial
|
